Dolby Laboratories (DLB) Misses Q2 EPS by 5c; Guides Q3 Lower

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $1.04, $0.05 worse than the analyst estimate of $1.09. Revenue for the quarter came in at $351.8 million versus the consensus estimate of $361.35 million.

GUIDANCE:

Dolby Laboratories sees Q3 2020 EPS of $0.18-$0.35, versus the consensus of $0.72. Dolby Laboratories sees Q3 2020 revenue of $225-250 million, versus the consensus of $309.08 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
• Rani Therapeutics Holdings, Inc. (RANI) Tops Q2 EPS by 1c
• Amaya (AYA) Misses Q2 EPS by 16c